CS261898B2 - Method of homogeneous granulation product making - Google Patents

Method of homogeneous granulation product making Download PDF

Info

Publication number
CS261898B2
CS261898B2 CS867084A CS708486A CS261898B2 CS 261898 B2 CS261898 B2 CS 261898B2 CS 867084 A CS867084 A CS 867084A CS 708486 A CS708486 A CS 708486A CS 261898 B2 CS261898 B2 CS 261898B2
Authority
CS
Czechoslovakia
Prior art keywords
weight
granulate
spraying
fluidized bed
temperature
Prior art date
Application number
CS867084A
Other languages
Czech (cs)
English (en)
Other versions
CS708486A2 (en
Inventor
Otto Klug
Heinrich Dr Schlunken
Dietmar Dr Siegel
Original Assignee
Hormon Chemie Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormon Chemie Muenchen filed Critical Hormon Chemie Muenchen
Publication of CS708486A2 publication Critical patent/CS708486A2/cs
Publication of CS261898B2 publication Critical patent/CS261898B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
CS867084A 1985-10-04 1986-10-02 Method of homogeneous granulation product making CS261898B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853535536 DE3535536A1 (de) 1985-10-04 1985-10-04 Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut

Publications (2)

Publication Number Publication Date
CS708486A2 CS708486A2 (en) 1988-06-15
CS261898B2 true CS261898B2 (en) 1989-02-10

Family

ID=6282808

Family Applications (1)

Application Number Title Priority Date Filing Date
CS867084A CS261898B2 (en) 1985-10-04 1986-10-02 Method of homogeneous granulation product making

Country Status (16)

Country Link
US (1) US4753803A (fr)
EP (1) EP0223033B1 (fr)
JP (1) JPH0717512B2 (fr)
AT (1) ATE65026T1 (fr)
BG (1) BG49498A3 (fr)
CA (1) CA1268706A (fr)
CS (1) CS261898B2 (fr)
DD (1) DD258992A1 (fr)
DE (2) DE3535536A1 (fr)
DK (1) DK167843B1 (fr)
ES (1) ES2038587T3 (fr)
GR (1) GR3002290T3 (fr)
HU (1) HU196712B (fr)
PL (1) PL148336B1 (fr)
SU (1) SU1743334A3 (fr)
YU (1) YU44931B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017383A (en) * 1989-08-22 1991-05-21 Taisho Pharmaceutical Co., Ltd. Method of producing fine coated pharmaceutical preparation
DE4441167C1 (de) * 1994-11-18 1996-03-14 Fraunhofer Ges Forschung Verfahren zur Trocknung von Blutplasma
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
EP1140235B2 (fr) * 1998-12-23 2007-12-19 ZLB Behring GmbH Granules de colle de fibrine et leur procede de fabrication
TWI332400B (en) * 2001-12-14 2010-11-01 Solvay Pharm Gmbh Preformulation for the tableting of natural mixtures of conjugated estrogens
TWI252111B (en) * 2001-12-14 2006-04-01 Solvay Pharm Gmbh Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1076888B (de) * 1956-12-18 1960-03-03 Karl Heinz Jaeger Dr Med Verfahren zur Gewinnung atmungsfoerdernder Wirkstoffe fuer therapeutische Zwecke
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
DE2143519B2 (de) * 1971-08-31 1974-05-30 Sandoz Ag, 8500 Nuernberg Verfahren zur Wirbelschichtgranulation pulverförmiger pharmazeutischer Mischungen
AT330953B (de) * 1972-11-16 1976-07-26 Solco Basel Ag Verfahren zur herstellung eines pharmazeutischen praparates zur verbesserung der zellatmung
DE3237303A1 (de) * 1982-10-08 1984-04-12 Glatt GmbH, 7851 Binzen Vorrichtung fuer wirbelschichtverfahren sowie damit durchfuehrbares verfahren
EP0106309A3 (fr) * 1982-10-12 1986-12-30 Kailash Kumar Dr. Prof. Gauri Extraits biologiquement actifs, procédé pour leur obtention, agents pharmaceutiques et cosmétiques les contenant et leur utilisation comme additifs pour des produits alimentaires et stimulants
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy

Also Published As

Publication number Publication date
DK167843B1 (da) 1993-12-27
PL261696A1 (en) 1988-01-07
JPH0717512B2 (ja) 1995-03-01
DE3535536A1 (de) 1987-04-09
CA1268706A (fr) 1990-05-08
DK472886A (da) 1987-04-05
PL148336B1 (en) 1989-10-31
DD258992A1 (de) 1988-08-10
YU169486A (en) 1987-12-31
JPS6287518A (ja) 1987-04-22
EP0223033A2 (fr) 1987-05-27
EP0223033A3 (en) 1988-06-29
HUT42328A (en) 1987-07-28
EP0223033B1 (fr) 1991-07-10
GR3002290T3 (en) 1992-12-30
ATE65026T1 (de) 1991-07-15
HU196712B (en) 1989-01-30
US4753803A (en) 1988-06-28
SU1743334A3 (ru) 1992-06-23
BG49498A3 (en) 1991-11-15
DK472886D0 (da) 1986-10-03
ES2038587T3 (es) 1993-08-01
CS708486A2 (en) 1988-06-15
YU44931B (en) 1991-04-30
DE3680183D1 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
AU623177B2 (en) Granular pharmaceutical formulations
KR100767928B1 (ko) 활성 성분의 맛이 차폐되고 활성 성분이 즉시 방출되는 코팅된 과립의 제조 방법
CA1297018C (fr) Composition pharmaceutique
US6558704B1 (en) Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
CA1255223A (fr) Formule de comprime
JPS62174013A (ja) 直打用ビタミン顆粒、その製造法および錠剤
HUT59588A (en) Retarde composition and process for producing it
HU196304B (en) Process for production of granulates of medical active substances with delaying effect
JPH0768140B2 (ja) 安定化された医薬物質、その製法および安定な医薬製剤
CZ160594A3 (en) Pharmaceutical preparation in the form of effervescent and/or disintegrating tablet or instant granulate, and process for preparing thereof
CZ20021765A3 (cs) Způsob potahování jader tablet a tablety tímto způsobem získané
KR920006909B1 (ko) 니트렌디핀을 함유하는 고상 약제의 제조 방법
JPH05320045A (ja) 錠剤に直接圧縮可能な医薬粉末組成物を製造するための噴霧乾燥法
CS261898B2 (en) Method of homogeneous granulation product making
US8268351B2 (en) Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
NZ521368A (en) Granulated particles of an active compound, with a film-forming coating resulting in the masked taste of said active compound
JPH0328404B2 (fr)
JPS6412248B2 (fr)
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
EP0557064B1 (fr) Composition à libération contrÔlée
US20020119194A1 (en) Pharmaceutical forms for the oral administration of mesna
SI8611694A8 (sl) Postopek za istočasno pridobivanje suhe snovi iz vodnih raztopin ekstraktnih snovi iz telečje krvi, iz katere smo odstranili beljakovine
CN116172970A (zh) 一种盐酸氟西汀长效口服制剂及制备方法
KR20130011110A (ko) 경구 투여용 조성물 및 이의 제조방법
JPH08175997A (ja) マレイン酸イルソグラジン経口投与用製剤およびその製造法

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20011002